News

Ruggell, Liechtenstein, 05 February 2008, Pantec Biosolutions AG, a private drug delivery company focused on innovative transdermal delivery of large molecular weight drugs, presented its novel P.L.E.A.S.E.® intraepidermal drug delivery platform at the Drug Delivery Partnerships 2008 conference in San Diego , 21-23 January 2008.

At the drug delivery conference, Pantec publicly unveiled its laser micro-poration technology P.L.E.A.S.E.® , a hand-held drug delivery device for the painless delivery of large molecular weight drugs. P.L.E.A.S.E.® stands for “Painless Laser Epidermal System”.

In his talk, held in the “Innovative Technology” session, Dr. Christof Böhler, CEO, presented to executives of Specialty Pharma, Pharma and Biotech, the development and production of the most efficient hand held laser microporator of its size, P.L.E.A.S.E.® . In addition, he disclosed the company’s latest preclinical data, demonstrating the drug delivery platform’s feasibility in the therapeutic areas of In Vitro Fertilisation (IVF), endocrinology and pain.

These achievements have enabled Pantec Biosolutions to implement its clinical strategy for IFV hormone treatment, with the ultimate objective of offering the P.L.E.A.S.E.® platform technology, combined with drug patch product solutions, to licensing partners in a one stop shop concept.

Dr. Christof Boehler, Pantec Biosolutions CEO, said: “We are proud to have presented our novel P.L.E.A.S.E.®  platform for the first time to our potential licensing partners. After just three years of development, we are now in the position to showcase the handheld device and to unveil promising preclinical data”.

Commenting on the development of the device, Pantec Biosolutions CTO, Thomas Bragagna, said: "In order to achieve such a task within three years, our team developed a second to none interdisciplinary approach to create a system that is as simple as it is high-tech. We have designed a drug delivery device which is convenient and safe to use for both medical professionals and patients”.

About Pantec Biosolutions and P.L.E.A.S.E.® 

Pantec Biosolutions is a private drug delivery company specialising in laser micro-poration technology to deliver large molecular weight drugs into the epidermis for systemic or topical uptake, removing unwanted therapeutic side effects including drug degradation. Its proprietary P.L.E.A.S.E.®  (Painless Laser Epidermal System) platform enables efficient, needle free and painless application of biopharmaceutical drugs, such as IVF hormones, in varying and individualised dosages through partnered patch technology.  

The Company’s P.L.E.A.S.E.®  platform is available both for the development of the Company’s own pipeline and for penetration into new markets through strategic partnerships. The technology is currently in clinical trials for the delivery of IVF hormone therapy, a market with an estimated value of US$1.5 – 2 billion.

Pantec Biosolutions is based in Ruggell, Liechtenstein .